Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Indometacin sodium trihydrate |
Is a |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin measurement |
Component |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Accidental indomethacin poisoning |
Causative agent (attribute) |
False |
Indometacin |
Inferred relationship |
Some |
|
Intentional indomethacin poisoning |
Causative agent (attribute) |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Indomethacin adverse reaction |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Allergy to indometacin |
Causative agent (attribute) |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin overdose |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Accidental indomethacin overdose |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Intentional indomethacin overdose |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indomethacin overdose of undetermined intent |
Causative agent (attribute) |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indometacin 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Product containing precisely indometacin 100 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin 75mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin 50mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin 25mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin 75mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin 25mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indometacin 50 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Product containing precisely indometacin 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indomethacin sodium 1.0mg/vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
|
Poisoning by indomethacin |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing indometacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing indometacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Intentional indomethacin poisoning |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing indometacin in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Accidental poisoning by indomethacin |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Allergy to indometacin |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indomethacin embryofetopathy refers to the manifestations that may be observed in a fetus or newborn when the mother has taken indomethacin, a potent prostaglandin inhibitor and tocolytic agent that can cross placenta, during pregnancy. Reported adverse fetal/neonatal effects include decreased renal function resulting in oligohydramnios, closure of the ductus arteriosus, and delayed cardiovascular adaptation at birth. These effects are usually transient and reversible. Indomethacin may also be a risk factor for cerebral injury (periventricular leukomalacia) and necrotizing enterocolitis in preterm infants. |
Causative agent (attribute) |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 75 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 100 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 100 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 75 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 75 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 25 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 75 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin sodium trihydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Indometacin |
Inferred relationship |
Some |
|
Indometacin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing only indometacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing only indometacin in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Product containing only indometacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Indometacin |
Inferred relationship |
Some |
|
Indometacin 50 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin 50 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |
Indometacin (as indometacin sodium) 1 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indometacin |
Inferred relationship |
Some |
1 |